Industry News

FDA Requests Sanofi And Regeneron To Assess Potential Risks Of Cholesterol Drug
ANI Pharmaceuticals Expands Generic Drug Development Agreement with Sterling Pharmaceuticals
Pernix Therapeutics Appoints Chief Operating Officer
FDA Clears Ventripoint VMS(TM) Heart Analysis System for Use in Patients with Pulmonary Arterial Hypertension
ANI Pharmaceuticals Expands Generic Drug Development Agreement with Sterling Pharmaceuticals
Access Pharmaceuticals Announces MuGard License Agreement With Hanmi Pharmaceutical In Korea
Antares Pharma Announces LEO Pharma�s Launch of OTREXUP (Methotrexate) Injection to Dermatologists for Adults with Psoriasis
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
FDA Designates Regado's REG1 in PCI as a Fast Track Development Program Enrollment in the Phase 3 REGULATE-PCI Trial is Ongoing for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
Antares Pharma Announces LEO Pharma�s Launch of OTREXUP (Methotrexate) Injection to Dermatologists for Adults with Psoriasis
Antares Pharma Announces LEO Pharma's Launch of OTREXUP (Methotrexate) Injection to Dermatologists for Adults with Psoriasis
Vitter, Lee, Manchin Want Investigation into Big PhRMA Allegedly Paying FDA for Drug Approval Process
Pernix Therapeutics Appoints Chief Operating Officer
BRIEF: Teva launches generic cancer drug
Xanodyne Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 8 New Drug Applications and 46 Abbreviated New Drug Applications for Propoxyphene...
MK Laboratories, Inc., et al.; Proposal To Withdraw Approval of Three Abbreviated New Drug Applications for Propoxyphene Products; Opportunity for a...
Xanodyne Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 8 New Drug Applications and 46 Abbreviated New Drug Applications for Propoxyphene...
Sun Pharma recalls batch of drug in US [India Business]
Navidea: FDA Accepts Additional sNDA to Further Expand Lymphoseek Labeling
Navidea: FDA Accepts Additional sNDA to Further Expand Lymphoseek Labeling
BRIEF: Teva launches generic cancer drug
U.S. FDA Approves Bydureon� Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer's Effexor XR 150 Mg Extended-Release Capsules and One Lot of Greenstone's...
Teva Announces Launch of Generic Xeloda Tablets 150 MG and 500 MG in the United States